Related Experiment Video

Updated: Apr 24, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

Lipid-lowering therapy in patients 75 years and older: clinical priority or superfluous therapy?

Binh An P Phan1, Vera Bittner2

  • 1Division of Cardiology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois 60153.

Progress in Cardiovascular Diseases
|September 14, 2014
PubMed

Insights

Statin therapy effectively lowers cholesterol and reduces cardiovascular disease risk in elderly patients. Further research is needed to optimize benefits and minimize side effects in this population.

Area of Science:

  • Gerontology
  • Cardiology
  • Pharmacology

Background:

  • Cardiovascular (CV) disease incidence and mortality rise with age.
  • Hypercholesterolemia, particularly elevated total and low-density-lipoprotein cholesterol, predicts CV events in the elderly.
  • Statin therapy is proven to lower cholesterol and reduce CV risk.

Purpose of the Study:

  • To evaluate the efficacy and safety of statin therapy in elderly populations for cardiovascular risk reduction.
  • To address the underrepresentation of elderly individuals in clinical trials for lipid-lowering therapies.
  • To inform cholesterol treatment guidelines for older adults.

Main Methods:

  • Review of existing clinical trial data and evidence regarding statin use in elderly patients.
  • Analysis of factors influencing statin therapy outcomes in older adults, including co-morbidities and poly-pharmacy.
  • Assessment of current cholesterol treatment guidelines for the elderly.

Main Results:

  • Limited clinical trial data support the benefit of statin therapy in the elderly.
  • Current guidelines endorse statin therapy for elderly hypercholesterolemia, with recommended caution.
  • Elderly patients, especially those over 75, are underrepresented in lipid-lowering therapy trials.

Conclusions:

  • Statin therapy is beneficial for hypercholesterolemia in the elderly, reducing cardiovascular risk.
  • Caution is advised due to co-morbidities and poly-pharmacy in this demographic.
  • Further research is essential to optimize statin benefits, minimize side effects, and improve quality of life in elderly patients.

Keywords:
DyslipidemiaElderlyHypercholesterolemiaStatin

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.2K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
634
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
383
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
392
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
375
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
846